Morgan Stanley 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:36 pm Purchase | 2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK | MORGAN STANLEY MS | 3,426,739 6.500% | 68,364 (+2.04%) | Filing |
| 2024-02-09 2:51 pm Purchase | 2023-12-31 | 13G | Stoke Therapeutics, Inc. STOK | MORGAN STANLEY MS | 3,358,375 7.500% | 910,161 (+37.18%) | Filing |
| 2023-02-10 11:50 am Purchase | 2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK | MORGAN STANLEY MS | 2,448,214 6.200% | 2,448,214 (New Position) | Filing |